Skip Nav Destination
SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis–Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate Cancer
Clin Cancer Res (2022) 28 (22): 4917–4925.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
Molecular features and race‐associated outcomes of SPOP ‐mutant metastatic castration‐resistant prostate cancer
- Andrew Stangl
- Christopher Wilner
- Pin Li
- Lucas Maahs
- Clara Hwang
- Amanda Pilling
The Prostate (2023)